Pharmaceutical Drugs Industry: Global Competitive Landscape 2021
Report Scope: This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innov... もっと見る
SummaryReport Scope:This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe and Japan. Report Includes: - 71 data tables and 54 additional tables - A brief general overview of the global pharmaceutical drugs industry competitive landscape - Analyses of the global market trends, with historic market revenue for 2016 to 2021, estimates for 2022, market forecasts for 2022-2026, and projections of compound annual growth rates (CAGRs) through 2027 - Assessment of major driving factors, opportunities and challenges in this innovation driven market, with emphasis on recent developments in the pharmaceutical industry - Highlights of the current and future market potential of pharmaceutical industry along with a detailed analysis of the competitive environment, regulatory scenario and clinical trails - Discussion of the industry value chain analysis providing a systematic study of key intermediaries involved, with emphasis on recent developments and region-specific macroeconomic factors on global pharmaceutical drugs marketplace - Market assessment of the COVID-19 impact on the global pharmaceutical drugs market, along with its implications on demand and supply, price impact and various government strategic decisions - Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues - Descriptive company profiles of the leading pharma manufacturers, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Pfizer Inc., Sanofi Corp., Takeda Pharmaceutical Co. Ltd. and Zydus Cadila Table of ContentsTable of ContentsChapter 1 Introduction 1.1 Study Goals and Objectives 1.2 Reasons for Doing This Study 1.3 Scope of Report 1.4 Methodology 1.4.1 Primary Data and Information Gathering 1.4.2 Secondary Data and Information Gathering 1.5 Market Revenue Forecasts 1.6 Analyst's Credentials 1.7 BCC Custom Research 1.8 Related BCC Research Reports Chapter 2 Market and Technology Background 2.1 Background and Definitions: Pharmaceutical Drugs 2.2 Uses of Various Drugs 2.3 Background: Innovation in the Pharmaceutical Industry 2.4 Stakeholders Involved in the Innovation Process 2.5 The Pharmaceutical Industry 2.6 The Cost of Pharmaceutical Drug Innovation 2.7 Current Trends in the Pharmaceuticals Industry 2.7.1 Digital Transformation and Technological Developments 2.7.2 Increasing R&D Spend and Shift Toward Modern Therapeutics and Technologies 2.7.3 Collaborations for Advanced Therapeutics 2.7.4 Market Consolidation for Strategic Growth and to Retain Market Leadership 2.8 Notable Trends 2.8.1 Income Growth in Developing Markets 2.8.2 Changing Structure of the Pharma and Healthcare Industry 2.8.3 Lifestyle Medicine 2.8.4 Patient-Centric Programs 2.8.5 Prevalence of Self-Care 2.8.6 Burden on Public Health System 2.9 Importance of Innovation 2.10 Challenges Facing the Sector 2.10.1 Public Health Systems 2.10.2 Balancing Patient Needs and Financial Sustainability 2.10.3 Competitiveness and Innovation 2.11 Market Dynamics 2.11.1 Drivers 2.11.2 Restraints 2.12 Opportunities 2.13 Strategies 2.14 Distribution Network 2.14.1 Asia-Pacific 2.14.2 U.S. 2.14.3 Europe 2.14.4 India 2.14.5 China 2.14.6 Japan 2.14.7 South Korea 2.15 Recommendations Chapter 3 Impact of COVID-19 on the Pharmaceutical Drug Market 3.1 Overview 3.2 COVID-19 Crisis 3.3 Impact on Market 3.4 Current Outlook 3.4.1 Implications on Cancer Diagnosis 3.4.2 Implications on Cancer Treatment 3.4.3 Impact on Oncology Pharmaceuticals Market 3.5 Implications on Cancer Treatment 3.5.1 Key Impacts of COVID-19 Chapter 4 Regulatory Structure: Pharmaceutical Drug Market 4.1 Regulatory Background 4.2 Regulatory Systems for Biopharmaceuticals by Region 4.2.1 U.S. 4.2.2 Europe 4.2.3 Japan 4.3 Regulatory Systems for Pharmaceuticals by Region 4.3.1 U.S. 4.3.2 Japan 4.3.3 India 4.3.4 Brazil 4.4 Regulations for Vaccines 4.4.1 Current Regulatory Issues for Vaccines 4.4.2 Moderna Vaccine Regulation in the U.K. 4.5 Key Regulatory Updates, 2020 4.5.1 Pharmaceuticals 4.5.2 Medical Devices 4.6 Code of Federal Regulations (CFR) 4.7 Good Manufacturing Compliance (GMP) Compliance 4.8 Establishment Registration 4.9 Drug Registration and Listing 4.10 Local Agent Requirements 4.10.1 Responsibilities of the U.S. Agent Chapter 5 Pricing and Reimbursement: Pharmaceuticals and Biologics 5.1 Pricing and Reimbursement Background 5.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region 5.2.1 U.S. 5.2.2 Europe 5.2.3 Japan 5.3 Pricing and Reimbursement Challenges for Pharmaceuticals 5.3.1 Patented Medicines Price 5.3.2 Prices of Older Drugs 5.4 Pricing and Reimbursement for Medical Devices by Region 5.4.1 U.S. 5.4.2 Europe 5.4.3 Japan 5.5 Other Parts of Asia-Pacific Chapter 6 Pharmaceutical Drugs Industry: Competitive Landscape 6.1 Overview 6.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers 6.2.1 Distribution Network 6.2.2 Trends 6.2.3 Mergers and Acquisitions 6.2.4 Recommendations 6.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers 6.3.1 Mergers and Acquisitions in Pharmaceutical Drugs Market 6.3.2 Agreements, Joint Ventures, Expansions, Divestments and Investments, Pharmaceuticals Market 6.3.4 New Product Launches and Approvals 6.4 Long-Term Outlook Chapter 7 Company Profiles ABBOTT ABBVIE INC. ALEXION PHARMACEUTICALS INC. AMGEN INC. ASTELLAS PHARMA INC. ASTRAZENECA ASAHI KASEI CORP. AUROBINDO PHARMA BAUSCH HEALTH COMPANIES INC. BAYER AG BIOGEN BOEHRINGER INGELHEIM INTERNATIONAL GMBH BRISTOL MYERS SQUIBB COMPANY CHUGAI PHARMACEUTICAL CO. LTD. CSL LTD. DAIICHI SANKYO CO. LTD. DR. REDDY’S LABORATORIES LTD. EISAI CO. LTD. ELI LILLY AND CO. ENDO INTERNATIONAL PLC GILEAD SCIENCES INC. GLAXOSMITHKLINE PLC GRIFOLS S.A. H. LUNDBECK A/S INCYTE IPSEN PHARMA JOHNSON & JOHNSON SERVICES INC. MALLINCKRODT PLC A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. MERCK & CO. INC. MERCK KGAA MODERNA INC. NOVARTIS AG NOVO NORDISK A/S OTSUKA HOLDINGS CO. LTD. PFIZER INC. REGENERON PHARMACEUTICALS INC. F. HOFFMANN-LA ROCHE LTD. (ROCHE) SANOFI SERVIER LABORATORIES SHANGHAI PHARMACEUTICALS HOLDING SHIONOGI & CO. LTD. CHINA NATIONAL PHARMACEUTICAL GROUP CORP. (SINOPHARM) STADA ARZNEIMITTEL AG SUMITOMO PHARMA CO. LTD. SUN PHARMACEUTICAL INDUSTRIES LTD. TAKEDA PHARMACEUTICAL CO. LTD. TEVA PHARMACEUTICAL INDUSTRIES LTD. UCB S.A. VERTEX PHARMACEUTICALS INC. VIATRIS INC. ZYDUS CADILA
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(産業機械)の最新刊レポート
BCC Research社のその他分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問BCC Research社はどのような調査会社ですか?BCCリサーチ(BCC Research)は1971年に設立され、様々な業界経験を持つアナリストと編集者によりトップクラスの市場情報源を長年提供している調査会社です。 設立初期は先端材料とプラ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |